Inventor · disambiguated record
Jesse M. Cedarbaum
Also filed as: CEDARBAUM JESSE · CEDARBAUM JESSE M
16 granted patents·10 pending applications·233 citations·filing 1999–2024
94Inventor score
Top patents by PatentIndex Score
26 records- 0195US7354581B2Therapeutic combination of a VEGF antagonist and anti-hypertensive agentREGENERON PHARMA·Filed 2006·Granted Apr 8, 2008·47 cites·11 claims
- 0294US7531172B2Methods of treating diseases with a VEGF antagonistREGENERON PHARMA·Filed 2006·Granted May 12, 2009·30 cites·10 claims
- 0394US7482002B2Method of administering and using VEGF inhibitors for the treatment of prostate cancerREGENERON PHARMA·Filed 2008·Granted Jan 27, 2009·23 cites·6 claims
- 0493US7479273B2Method of administering and using VEGF inhibitors for the treatment of renal cell cancerREGENERON PHARMA·Filed 2008·Granted Jan 20, 2009·9 cites·6 claims
- 0593US7479275B2Method of administering and using VEGF inhibitors for the treatment of colorectal cancerREGENERON PHARMA·Filed 2008·Granted Jan 20, 2009·9 cites·6 claims
- 0693US7479272B2Method of administering and using VEGF inhibitors for the treatment of breast cancerREGENERON PHARMA·Filed 2008·Granted Jan 20, 2009·9 cites·6 claims
- 0793US7449182B2Therapeutic combination of a VEGF antagonist and anti-hypertensive agentREGENERON PHARMA·Filed 2007·Granted Nov 11, 2008·26 cites·5 claims
- 0893US7354580B2Method of administering and using VEGF inhibitors for the treatment of human cancerREGENERON PHARMA·Filed 2005·Granted Apr 8, 2008·13 cites·7 claims
- 0992US7351411B2Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF)REGENERON PHARMA·Filed 2006·Granted Apr 1, 2008·23 cites·12 claims
- 1091US7482001B2Method of administering and using VEGF inhibitors for the treatment of non small cell lung cancerCEDARBAUM JESSE M·Filed 2008·Granted Jan 27, 2009·9 cites·6 claims
- 1189US7479274B2Method of administering and using VEGF inhibitors for the treatment of pancreatic carcinomaREGENERON PHARMA·Filed 2008·Granted Jan 20, 2009·9 cites·6 claims
- 1287US7354582B2Use of VEGF antagonists for the treatment of malignant gliomasREGENERON PHARMA·Filed 2006·Granted Apr 8, 2008·13 cites·12 claims
- 1381US8388963B2Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereofVRIGNAUD PATRICIA·Filed 2009·Granted Mar 5, 2013·7 cites·14 claims
- 1476US2025032042A1Methods for evaluating patientsBIOGEN MA INC·Filed 2024·Application pending·0 cites
- 1571US2023337967A1Methods for evaluating patientsBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 1662US10272082B2Combination ALS therapyCEDARBAUM JESSE·Filed 2012·Granted Apr 30, 2019·1 cites·17 claims
- 1762US2022039739A1Methods for evaluating patientsBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 1859US8748496B2Methods of treatment of hyperuricemia and associated disease statesCEDARBAUM JESSE M·Filed 2009·Granted Jun 10, 2014·0 cites·19 claims
- 1953US2013184205A1Antitumor combinations containing a vegf-inhibiting agent and 5fu or a derivative thereofREGENERON PHARMA·Filed 2013·Application pending·0 cites
- 2053US2006178305A1Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereofAVENTIS PHARMA SA·Filed 2005·Application pending·0 cites
- 2150US2018064386A1Methods for evaluating patientsBIOGEN MA INC·Filed 2017·Application pending·0 cites
- 2245US6656474B1Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disordersREGENERON PHARMA·Filed 1999·Granted Dec 2, 2003·5 cites·28 claims
- 2343US2015306043A1Combination treatments for bipolar disordersABUSHAKRA SUSAN·Filed 2013·Application pending·0 cites
- 2442US2014194428A1Combination treatments for bipolar disordersELAN PHARM INC·Filed 2012·Application pending·0 cites
- 2536US2005281822A1Method of administering and using VEGF inhibitors for the treatment of malignant pleural effusionCEDARBAUM JESSE M·Filed 2005·Application pending·0 cites
- 2632US2014243422A1Methods of treating behavioral and psychiatric disordersABUSHAKRA SUSAN·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jesse M. Cedarbaum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →